Patient Home Monitoring | StockChase
166
Patient Home Monitoring (PHM-X)

Last Price Recorded: $0.3150 on 2017-12-12

ON STOCKCHASE SINCE Sep 2013

other services
166
Patient Home Monitoring (PHM-X)

Last Price Recorded: $0.3150 on 2017-12-12

ON STOCKCHASE SINCE Sep 2013

other services

Patient Home Monitoring


Signal Opinion Expert
COMMENT
Patient Home Monitoring(PHM-X) 

November 15, 2017

Ranks 135 out of 700 stocks. Overall numbers seem reasonable. The latest earnings were slightly negative at -2.4%. Earnings estimates are expected to be $.03, but it is only covered by one analyst. Seems to be expensive.

other services

Ranks 135 out of 700 stocks. Overall numbers seem reasonable. The latest earnings were slightly negative at -2.4%. Earnings estimates are expected to be $.03, but it is only covered by one analyst. Seems to be expensive.

other services
Robert McWhirter

President, Selective Asset Mana...

PricePrice
$0.285
Owned Owned
No

COMMENT

Just announced they were going to be splitting the company. He's been waiting for this for some time. It was probably about a year ago they said they were going to be splitting the company into 2 pieces. They’ve been working with CRA to get everything figured out. They are going to have a shareholders meeting and it is going to be voted on. He is surprised this is trading where it is, but it was probably a function of legacy issues, and is now probably a function of tax loss selling.

other services

Just announced they were going to be splitting the company. He's been waiting for this for some time. It was probably about a year ago they said they were going to be splitting the company into 2 pieces. They’ve been working with CRA to get everything figured out. They are going to have a shareholders meeting and it is going to be voted on. He is surprised this is trading where it is, but it was probably a function of legacy issues, and is now probably a function of tax loss selling.

other services
Bruce Campbell (2)

President & Portfolio Manager, Stone Castle Investm...

PricePrice
$0.315
Owned Owned
Unknown

HOLD

It was the ‘go-go’ stock a few years ago and now the one everyone hates.  He gets a lot of calls.  A lot of people are frustrated as they go through restructuring.  They feel they are very close to getting approval to spin the company off into two.  He focuses on pure numbers.  They are fantastic.  They grew their business to make up for the healthcare benefits cuts previously.  The principles there now have a lot of stock that they bought at higher prices.  They are growing organically.  People need to be patient during the restructuring.

other services

It was the ‘go-go’ stock a few years ago and now the one everyone hates.  He gets a lot of calls.  A lot of people are frustrated as they go through restructuring.  They feel they are very close to getting approval to spin the company off into two.  He focuses on pure numbers.  They are fantastic.  They grew their business to make up for the healthcare benefits cuts previously.  The principles there now have a lot of stock that they bought at higher prices.  They are growing organically.  People need to be patient during the restructuring.

other services
Bruce Campbell (2)

President & Portfolio Manager, Stone Castle Investm...

PricePrice
$0.305
Owned Owned
Unknown

DON'T BUY
Patient Home Monitoring(PHM-X) 

September 21, 2017

This seems to have been stuck in the $0.25-$0.50 netherworld for the last 3-4 months. It has been banging into a kind of moving average. Chart shows a huge base, and if it ever got its act together, it would probably get a lot of attention. A 1-year chart shows it bottomed at around $0.13-$0.14 followed by a little break out, a little resistance and a slowly falling trend line. Until it got above $0.50, he would not be interested. Being a Venture stock, it is probably very susceptible to news.

other services

This seems to have been stuck in the $0.25-$0.50 netherworld for the last 3-4 months. It has been banging into a kind of moving average. Chart shows a huge base, and if it ever got its act together, it would probably get a lot of attention. A 1-year chart shows it bottomed at around $0.13-$0.14 followed by a little break out, a little resistance and a slowly falling trend line. Until it got above $0.50, he would not be interested. Being a Venture stock, it is probably very susceptible to news.

other services
Hap (Robert) Sneddon FCSI

Chief Portfolio Manager & Founder, Castlemoore Inc....

PricePrice
$0.310
Owned Owned
No

COMMENT
Patient Home Monitoring(PHM-X) 

September 14, 2017

Right now, they are waiting for some regulatory information to come back, both from a tax perspective as well as a market perspective, when dealing with the regulators. Once that comes out, then it will go to a shareholder vote to split the company up. Thinks they have turned the corner and have started to execute very well. Have had 3 quarters of growing earnings and generating cash flow and higher revenue. Stock is super cheap.

other services

Right now, they are waiting for some regulatory information to come back, both from a tax perspective as well as a market perspective, when dealing with the regulators. Once that comes out, then it will go to a shareholder vote to split the company up. Thinks they have turned the corner and have started to execute very well. Have had 3 quarters of growing earnings and generating cash flow and higher revenue. Stock is super cheap.

other services
Bruce Campbell (2)

President & Portfolio Manager, Stone Castle Investm...

PricePrice
$0.310
Owned Owned
Unknown

COMMENT
Patient Home Monitoring(PHM-X) 

September 5, 2017

This was a super stock in the beginning. It has the makings of something with new management in the US. Supposedly there is going to be a division of the assets. However, don’t forget, that everything that is in the medical sector is getting Trump-ized, so it is difficult at the moment. There is only one analyst on this, and he keeps giving it a “Buy”.

other services

This was a super stock in the beginning. It has the makings of something with new management in the US. Supposedly there is going to be a division of the assets. However, don’t forget, that everything that is in the medical sector is getting Trump-ized, so it is difficult at the moment. There is only one analyst on this, and he keeps giving it a “Buy”.

other services
Michael Smedley

Exec VP & Chief Investment Officer, Morgan Meighan & Ass...

PricePrice
$0.330
Owned Owned
Unknown

DON'T BUY

Great price momentum.  Valuation is still not there.  It is expensive and there is not a ton of earnings. 

other services

Great price momentum.  Valuation is still not there.  It is expensive and there is not a ton of earnings. 

other services
Jason Mann

CIO & Co-Founder, Edgehill Patners...

PricePrice
$0.390
Owned Owned
Yes

BUY

Their last couple of quarters have been a very nice turnaround. It was a big acquisition story. Now things are getting back into control.  He is not big on turnarounds until they have turned around a little further.  If they can put in a couple more quarters they will do much better.  You’ve got some time to buy it.

other services

Their last couple of quarters have been a very nice turnaround. It was a big acquisition story. Now things are getting back into control.  He is not big on turnarounds until they have turned around a little further.  If they can put in a couple more quarters they will do much better.  You’ve got some time to buy it.

other services
Peter Hodson

CEO & Head of Research, 5i Research Inc....

PricePrice
$0.450
Owned Owned
Unknown

COMMENT

Has not met the new management. This has 2 different parts, one being in the US.

other services

Has not met the new management. This has 2 different parts, one being in the US.

other services
Michael Smedley

Exec VP & Chief Investment Officer, Morgan Meighan & Ass...

PricePrice
$0.480
Owned Owned
Yes

DON'T BUY

They changed their business model over the years, but he is skeptical of it.  There could be regulatory changes.  He feels it is better not to take those excessive risks at this time.

other services

They changed their business model over the years, but he is skeptical of it.  There could be regulatory changes.  He feels it is better not to take those excessive risks at this time.

other services
Andrey Omelchak

President & CIO, LionGuard Capital Ma...

PricePrice
$0.400
Owned Owned
Unknown

TOP PICK

Continues to grow organically, and has done a phenomenal job. They had the reimbursement cut a year ago, and since that time they have actually gained back all their business and continue to grow. The company is going to be split and are currently in the regulatory process. Still trading at a very cheap valuation, and can go much higher from here. (Analysts’ price target is $0.85.)

other services

Continues to grow organically, and has done a phenomenal job. They had the reimbursement cut a year ago, and since that time they have actually gained back all their business and continue to grow. The company is going to be split and are currently in the regulatory process. Still trading at a very cheap valuation, and can go much higher from here. (Analysts’ price target is $0.85.)

other services
Bruce Campbell (2)

President & Portfolio Manager, Stone Castle Investm...

PricePrice
$0.435
Owned Owned
Yes

BUY

He would like to see more consistency, but it looks pretty good to him.  It had a rise and fall, but has been rallying recently.

other services

He would like to see more consistency, but it looks pretty good to him.  It had a rise and fall, but has been rallying recently.

other services
Matt Kacur

President, FSA Financial Scienc...

PricePrice
$0.400
Owned Owned
Unknown

COMMENT

This looks pretty good. Reached a peak in 2015 and then went into a tail spin and then had a very low volatility base in the latter part of 2016. It is just now starting to make higher highs and higher lows, which is a good thing.

other services

This looks pretty good. Reached a peak in 2015 and then went into a tail spin and then had a very low volatility base in the latter part of 2016. It is just now starting to make higher highs and higher lows, which is a good thing.

other services
Keith Richards

Portfolio Manager, ValueTrend Wealth Ma...

PricePrice
$0.400
Owned Owned
Unknown

DON'T BUY

It was in an upward trend and then broke it and is in a downward trend.  It is underperforming the TSX and broke below the 20 & 50 day moving average. 

other services

It was in an upward trend and then broke it and is in a downward trend.  It is underperforming the TSX and broke below the 20 & 50 day moving average. 

other services
Don Vialoux

Research Analyst, TimingTheMarket.CA &...

PricePrice
$0.380
Owned Owned
Unknown

COMMENT

Take some profits or be a buyer? This has contracted a bit again. The main problem is that you don’t really get too much presence of them in the marketplace compared to their beginning. An issue that is difficult to handle is that they are going to split into 2 companies in a few months. When they split, that would suggest that instead of having an itsy-bitsy $.38 stock you are going to have 2 itsy-bitsy $.20 stocks. One is probably going to be dealing with sleep apnea type stuff and the other with the traditional home monitoring, which is still really experimental. He would probably underweight this until he could see the whites of their eyes.

other services

Take some profits or be a buyer? This has contracted a bit again. The main problem is that you don’t really get too much presence of them in the marketplace compared to their beginning. An issue that is difficult to handle is that they are going to split into 2 companies in a few months. When they split, that would suggest that instead of having an itsy-bitsy $.38 stock you are going to have 2 itsy-bitsy $.20 stocks. One is probably going to be dealing with sleep apnea type stuff and the other with the traditional home monitoring, which is still really experimental. He would probably underweight this until he could see the whites of their eyes.

other services
Michael Smedley

Exec VP & Chief Investment Officer, Morgan Meighan & Ass...

PricePrice
$0.380
Owned Owned
Yes

Showing 1 to 15 of 166 entries
<< < 1 2 3 4 5 > >>
Post Comment

1 Comment

idaustin

February 2nd 2016 at 7:44pm

Absolutely amazing that all these experts got sold on the story and believed it all the way down. Expert is Latin for ostrich


You must be logged in to comment.

Successfully Saved Company